Ignite Creation Date:
2025-12-24 @ 9:09 PM
Ignite Modification Date:
2025-12-25 @ 7:21 PM
Study NCT ID:
NCT04996004
Status:
TERMINATED
Last Update Posted:
2024-12-11
First Post:
2021-08-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study to Learn About the Study Medicine (Called Ontorpacept or TTI-621) Given Alone and in Combination With Doxorubicin in People With Leiomyosarcoma
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-06-22
Start Date Type:
ACTUAL
Primary Completion Date:
2023-12-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-07
Completion Date Type:
ACTUAL
First Submit Date:
2021-08-02
First Submit QC Date:
None
Study First Post Date:
2021-08-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2024-11-14
Results First Submit QC Date:
None
Results First Post Date:
2024-12-11
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-14
Last Update Post Date:
2024-12-11
Last Update Post Date Type:
ACTUAL